| Brand Name | Manta Vascular Closure Device 14F |
| Common Device Name | DEVICE, HEMOSTASIS, VASCULAR |
| Manufacturer (Section D) |
| Essential Medical, Inc. |
| exton PA |
|
| Manufacturer (Section G) |
| Teleflex Medical |
| rancho el descanso |
|
| tecate 21478 |
|
MX
21478
|
|
| Manufacturer Contact |
|
katharine
tarpley
|
| 3015 carrington mill blvd |
| morrisville, NC 27560
|
|
| MDR Report Key | 50555490 |
| Report Number | 3003898360-2026-00376 |
| Device Sequence Number | 13424633 |
| Product Code |
MGB
|
| UDI-Device Identifier | 10841156111359 |
| Combination Product (Y/N) | N |
| Initial Reporter State | MS |
| Initial Reporter Country | US |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
User Facility,Company Representative |
| Type of Report
| Initial,Followup |
| Report Date (Section B) |
08/04/2026 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
No
|
| Is this a Product Problem Report? |
Yes
|
| Operator of Device |
Health Professional
|
| Device Catalogue Number | 2156 |
| Device Lot Number | 73K2500622 |
| Was Device Available for Evaluation? |
No
|
| Is the Reporter a Health Professional? |
No
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 08/04/2026 |
| Supplement Date Received by Manufacturer | 09/23/2026
|
| Initial Report FDA Received Date | 09/02/2026 |
| Supplement Report FDA Received Date | 09/28/2026
|
| Was Device Evaluated by Manufacturer? (Y/N) |
Device Not Returned to Manufacturer
|
| Date Device Manufactured | 10/15/2025 |
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
Concomitant Medical Products and Therapy/Usage Dates | Not Reported. |
| Outcome Attributed to Adverse Event |
Required Intervention;
|
| Patient Age | 79 YR |
| Patient Sex | Female |
|
|